Inventor
RUDOLPH RAINER
DE30 patents
⚠️ This page may combine multiple inventors who share the name “RUDOLPH RAINER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BOEHRINGER MANNHEIM GMBH
17 patentsUS5919757AJul 6, 1999
Aqueous pharmaceutical preparations of G-CSF with a long shelf life
BOEHRINGER MANNHEIM GMBH86 citations96
US5919443AJul 6, 1999
Stable lyophilized pharmaceutical preparations of G-CSF
BOEHRINGER MANNHEIM GMBH62 citations96
US5453363ASep 26, 1995
Process for the activation of t-PA or Ing after genetic expression in prokaryotes
BOEHRINGER MANNHEIM GMBH77 citations96
US5672691ASep 30, 1997
Recombinant core streptavidin
BOEHRINGER MANNHEIM GMBH34 citations92
US5593865AJan 14, 1997
Process for the activating of gene-technologically produced, heterologous, disulphide bridge-containing eukaryotic proteins after expression in prokaryotes
BOEHRINGER MANNHEIM GMBH33 citations92
US5489528AFeb 6, 1996
Recombinant core-streptavidin
BOEHRINGER MANNHEIM GMBH21 citations92
US5077392ADec 31, 1991
Process for activation of recombinant protein produced by prokaryotes
BOEHRINGER MANNHEIM GMBH38 citations92
US4933434AJun 12, 1990
Process for obtaining renatured proteins
BOEHRINGER MANNHEIM GMBH11 citations74
US5409699AApr 25, 1995
Compositions containing glycosylated molecules having human tissue type plasminogen activator enzymatic activity
BOEHRINGER MANNHEIM GMBH11 citations73
US5352452AOct 4, 1994
Stabilized compositions containing non-glysylated human tissue type plasminogen activator derivative K2P pro
BOEHRINGER MANNHEIM GMBH11 citations73
US5223256AJun 29, 1993
Thrombolytically active non-glycosylated protein
BOEHRINGER MANNHEIM GMBH14 citations73
US5618927AApr 8, 1997
Process for the reactivation of denatured protein
BOEHRINGER MANNHEIM GMBH6 citations71
US5578710ANov 26, 1996
Activation of recombinant proteins
BOEHRINGER MANNHEIM GMBH12 citations71
US5434067AJul 18, 1995
Process for the production and renaturation of recombinant, biologically active, eukaryotic alkaline phosphatase
BOEHRINGER MANNHEIM GMBH12 citations71
US5352453AOct 4, 1994
Compositions containing non-glycosylated human tissue type plasminogen activator
BOEHRINGER MANNHEIM GMBH4 citations62
US5965424AOct 12, 1999
Methods for making neisseria or hemophilus IgA protease and DNA encoding the proteases
BOEHRINGER MANNHEIM GMBH5 citations60
US5854048ADec 29, 1998
Method for treating thromboembolic conditions using thrombolytically active proteins
BOEHRINGER MANNHEIM GMBH1 citations52
HOFFMANN LA ROCHE
3 patentsUS6455279B1Sep 24, 2002
Process for the production of naturally folded and secreted proteins by co-secretion of molecular chaperones
HOFFMANN LA ROCHE44 citations89
US6437095B1Aug 20, 2002
Method for producing chimeric polypeptides
HOFFMANN LA ROCHE41 citations88
US6309861B1Oct 30, 2001
Process for the production of naturally folded and secreted proteins
HOFFMANN LA ROCHE11 citations71